Phase 1, Open Label Study to Evaluate the Effect of Omeprazole and Ritonavir on GSK2336805 Pharmacokinetics in Healthy Adults
Phase of Trial: Phase I
Latest Information Update: 26 Jul 2017
At a glance
- Drugs JNJ 56914845 (Primary) ; Omeprazole; Ritonavir
- Indications Gastrointestinal ulcer; Hepatitis C; HIV infections
- Focus Pharmacokinetics
- Sponsors GlaxoSmithKline
- 09 Dec 2011 Actual end date (Nov 2011) added as reported by ClinicalTrials.gov.
- 09 Dec 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 18 Nov 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.